ADI2020 Speaker Paola Barbarino

Paola is CEO of Alzheimer’s Disease International. Prior to this, she was CEO of LIFE and occupied senior positions with Cass Business School, Tate, British Library and IIED. She is a Board Member of the World Dementia Council, a Trustee of The Postal Museum and of Lauderdale House. Previously she was a Non-Executive Director of the Non-Communicable Disease Alliance (NCDA), a Trustee of Shelter, the housing/homelessness charity, and of MLA London. She holds a degree cum laude in Classics from Federico II Napoli University, an MA in Field and Analytical Techniques in Archaeology and an MA in Library and Information Science both from University College London.

ADI2020 Speaker Chris Lynch

Chris Lynch is Deputy CEO at Alzheimer’s Disease International and Director of Policy, Communications & Publications.

Chris has over 25 years’ experience in communications, marketing, business development, policy, publications and events, working in the private, public and not for profit sectors.

On the director team at Alzheimer Scotland, Chris had responsibility for Communications, External Affairs, Marketing, Membership, Events, International liaison and Digital strategy, plus key fundraising activity.

With a passion for digital communication and transformation, he became a Scottish Government Digital Champion in 2016.

Chris has run his own marketing and business development consultancy, Future Marketing, as well as a successful hospitality business.

His pro-bono work includes start up and third sector business advice.

ADI2020 Speaker Masahiko Yamamoto

Masahiko Yamamoto is an office manager of Asahi Shimbun Social Welfare Organization Osaka office. Masahiko has been trying to build and spread spirit of the Dementia Friendly Community in Japan since he joined the organization. He planned international conferences about Dementia Friendly Community to introduce the latest attempts going on all over the world. Recently, his aim is that his newspaper company, Asahi Shimbun making dementia friendly. Masahiko used to be a photo journalist and was awarded the most honorable Japan Newspaper and Publishers & Editors Association award in 2005 on photo reporting of over 500 passengers who died in the Japan Railway train crash.

Shamil Mohamed is a retired hotelier and a registered client at the Lanka Alzheimer’s Foundation’s Activity Centre. He started experiencing difficulties in walking at age 54 and was subsequently diagnosed with fluid in the brain, which is a rare cause of dementia. He has been advocating for his country’s government to adopt a national plan for dementia that will enhance the quality of life for persons with dementia and their carers.

Professor Miia Kivipelto, MD, PhD is Deputy Head of KI-ARC and Professor in Clinical Geriatric Epidemiology at Karolinska Institutet in Stockholm. She is also Research Director of Neuroepidemiology unit at University of Eastern Finland. She is combining research with clinical medicine, working also as senior geriatrician at the Memory Clinic, Karolinska University Hospital. She has been working in several clinical trials concerning cognitive impairment and AD and is now Deputy Head of the Clinical Trials Unit.

Prof. Kivipelto is the principal investigator in the large population based Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study and in FINGER. Her research focus is the effects of and interactions between lifestyle-related and genetic factors on cognitive decline/dementia and prevention of AD and other aging-related diseases. Prof. Kivipelto has several PhD and post-doctoral students in her research group and she is involved in many international networks and scientific/steering committees. The unique combination as neuroepidemiologist and geriatrician gives a natural platform for the translational research proposed in the research plan.

ADI2020 Speaker Christopher Chen

Dr Christopher Chen is a Senior Clinician-Scientist, Associate Professor at the Departments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and Director of the Memory Aging and Cognition Centre, National University Healthcare System.

His pre-clinical studies were at Fitzwilliam College, Cambridge University and his clinical training was at New College, Oxford University. He was elected the Janssen Junior Research Fellow at Worcester College, Oxford University and was a Visiting Research Fellow at the Department of Neurochemistry, Institute of Neurology, London.

Since returning to Singapore, Dr Chen has developed multi-disciplinary research programmes with extensive international collaborations. His major research and clinical interests are in neuroimaging, molecular biology and treatment of stroke and dementia resulting in over 350 peer reviewed publications. He is the Principal Investigator for several trials including the SINgapore GERiatric intervention study to reduce physical frailty and cognitive decline (SINGER), serves on journal editorial boards and has been a member of trial steering committees and advisory panels.

Currently he is President of the Asian Society Against Dementia, Secretary-Treasurer of the Asian & Oceanian Association of Neurology and Immediate Past Chair of the International Society for Vascular Behavioural and Cognitive Disorders.

Gill Livingston is professor of psychiatry of older people in University College London, Division of Psychiatry, head of mental health care of older people’s research & consultant psychiatrist, Camden & Islington NHS FT in the UK.

She led the Lancet International Commission on Dementia Prevention, Intervention and Care, launched in 2017. It contained the first life course analysis of potentially modifiable risks in dementia. She works to the commission’s strapline “Acting now on dementia prevention, intervention, and care will vastly improve living and dying for individuals with dementia and their families, and in doing so, will transform the future for society.”  She also leads the new update to the Lancet standing commission. She will discuss new material from it.

Her other research includes the START project which successfully reduced depression in carers in a randomised controlled trial, demonstrating clinical and cost effectiveness and long term effectiveness. She has also researched interventions in care homes; non-pharmacological interventions for sleep in dementia and dementia and interventions in minority ethnic groups.

ADI2020 Speaker Roman Szydlowski

Mr. Roman Szydlowski was born in 1944 in the village of Wolnowacha in Ukraine, the son of Karol and Regina Szydlowski who fled to Soviet Union from Poland during WWII.

He was enrolled in the Royal Institute of Technology in Stockholm studying electrical engineering from 1970 – 1974. He worked for Ericson as an object leader regarding mobile base stations. He was diagnosed with prostate cancer in 2002 and had contractual retirement. After treatment and progression of health, he started working with programming burglar alarms for a small company. In 2011, he was diagnosed with colon cancer which he later recovered from. In 2012, he had a surgery because of a metastasis in his lung.

Mr. Szydlowski was diagnosed with early Alzheimers in 2009 and started taking the drug Aricept against the progression of Alzheimers the same year. In 2018, he was enrolled in a special programme regarding Alzheimers which ended in March 2019. In July 2019, he had better results regarding his cognitive abilities than his results at the same type of test in 2018.

Mr. Szydlowski married Alina Hanczyc in 1981 and they have two children. His hobbies are bridge, classical music and sports.

ADI2020 Speaker John Morris

John C. Morris, MD, is the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology; Professor of Pathology and Immunology; Professor of Physical Therapy; Professor of Occupational Therapy; and Director of the Charles F. and Joanne Knight Alzheimer’s Disease Research Center at Washington University School of Medicine. Dr. Morris’ research interests include healthy aging and Alzheimer dementia, antecedent biomarkers for Alzheimer disease, and trials of investigational drugs for the treatment of Alzheimer dementia.

Dr. Morris has authored 4 books and more than 600 published articles (current h-index 127). Dr. Morris is a member of several professional societies and serves on numerous scientific and community advisory boards. He has received many honors and awards, including the MetLife Award for Medical Research in Alzheimer’s Disease (2004); the Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Dementias (2005); and the Carl and Gerty Cori Faculty Achievement Award, Washington University (2010).  In 2013, he received the 2013 Peter H. Raven Lifetime Achievement Award from the Academy of Science of St. Louis, the Washington University School of Medicine Second Century Award, and the 2013 Medical & Scientific Honoree from the Alzheimer’s Association He is ranked in the top 1% of investigators in the field of Neuroscience and Behavior by Essential Science Indicators database.

ADI2020 Speaker John Morris

Dr. Hamed Al Sinawi is a senior consultant old age psychiatrist at Sultan Qaboos University in Muscat and the chairman and founder of Oman Alzheimer’s Society. He completed his residency and higher psychiatry training in London and establish a memory clinic in Oman in 2011. Along with his clinical work, Dr Al Sinawi is a trainer for the Residents at the Omani board of psychiatry and Research supervises for residents and medical students. His research interests are in the area of geriatric psychiatry, mental health stigma and medical education. He also conducts regular health education campaigns in dementia to the general public and health care professionals.

ADI2020 Speaker Michael Schmieder

For 30 years, Michael Schmieder led the Sonnweid in Wetzikon, Switzerland. He developed models for caring for people with dementia. At the end of 2015, he handed over the management of the Sonnweid. Since then he has worked as a consultant and speaker. In the same year, he published with Uschi Entenmann the book «Dement, aber nicht bescheuert».

Dr. Violet Okech-Helu is a Consultant Psychiatrist/ Counselor with more than 15 years of experience in the field of mental health. She chairs Adult Psychiatry and Coordinates Mental Health Research at the Department of Mental Health, KNH, Nairobi, Kenya. She is an Honorary Lecturer in the Department of Psychiatry, University of Nairobi. She played a key role in Mental Health Services development in Kenya and East Africa as the Founding President of the Eastern Africa Young Psychiatrists and Trainees Association (EAYPTA) and was the first female to be the National Vice Chairperson of Kenya Psychiatric Association.

Dr. Okech is an expert in Gender, HIV care and Public Mental Health and Policy. She is an alumnus of the Johns Hopkins University, USA, MPH (Masters in Public Health) and Fulbright Hubert. H. Humphrey Programs and of the University of Nairobi, Medical School. She is also the Kenya Psychiatric Association Ambassador to ADI.

Dr. Okech is passionate about Women’s Mental Health, Mood Disorders, Dementia Care and promoting Quality, Dignified Care for the Elderly.

Martin Knapp is Professor of Social Policy and Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE). He has also been Director of the NIHR School for Social Care Research since 2009.

Professor Knapp has been working for many years in the fields of long-term care, social care, and mental health policy and practice. His current research emphases are primarily dementia, child and adult mental health, autism and long-term social care. Much of his work has an economic focus, and in all of it he seeks to tease out the policy and practice implications. He has published almost 600 peer-review journal papers and 15 books. His work has had numerous impacts on policy and practice in these areas.

ADI2020 Speaker Lim Wee Shiong

Dr. and A/Prof. Lim is Senior Consultant at Department of Geriatric Medicine and research track lead at the Institute of Geriatrics and Active Ageing, Tan Tock Seng Hospital. He is faculty advisor to National Healthcare Group Health Outcomes Medical Education Research (NHG-HOMER); Adjunct Associate Professor of Yong Loo Lin School of Medicine, NUS; council member, Chapter of Clinician Educators; Fellow of the American Geriatric Society; and Associate Fellow of the Association for Medical Education in Europe. He is also adjunct faculty of the Centre for Healthcare Innovation and a member of the Research Management Committee, Geriatric Education and Research Institute.

Awarded the outstanding alumni award 2016 from the Massachusetts General Hospital Institute of Health Professions, Boston, USA, his enthusiasm in his role as “Geriatrician Educator Researcher” is evidenced by his comprehensive track record of scholarly work, including over 100 peer-reviewed publications; editorial board member of the Journal of Nutrition, Health and Aging and guest associate editor for Frontiers in Medicine and Frontiers in Aging Neuroscience; reviewer for major national   grants, international journals and conferences; and research and teaching awards in the fields of Geriatric Medicine and Health Professions Education. He is chair of the scientific committee for the Asia Pacific Geriatrics Conference in 2016, and co-chair of the local scientific committee for ADI 2020.

Dr. Lim has completed fellowships in dementia and cognitive disorders at Washington University, St Louis, Successful Aging Programme at St Louis University, and Trans-disciplinary Frailty Research To Achieve Healthy Ageing at University of Adelaide. As principal investigator of the seminal GERI-LABS and GERI-LABS2 studies, he leads a multi-disciplinary team of researchers in conducting cutting-edge research in the areas of frailty and sarcopenia. His passion and dedication in raising regional interest and standards in the field of geriatric medicine, frailty and sarcopenia are evident in his involvement with the Asia Pacific Geriatrics Network; the Asian Working Group for Sarcopenia; and a co-author of the widely-cited Asia-Pacific Clinical Practice Guidelines for frailty.

In the area of dementia research, Dr. Lim has been instrumental in demonstrating the salience of the multidimensional approach to caregiver burden. In particular, his seminal work on “worry about performance” caregiver burden has also been replicated in fields outside of dementia. His research in the area of caregiving is now focusing on the complementary and protective role of mastery against adverse caregiver outcomes. He is also the lead author of the highly cited Cochrane review on the role of omega-3 supplementation in prevention of dementia. His other areas of interest in the area of cognitive disorders include cognitive frailty, delirium, and mild cognitive impairment.

ADI2020 Speaker Joyce Simard
ADI2020 Speaker Ladislav Volicer

Joyce Simard, MSW, is an Adjunct Associate Professor School of Nursing, University of Western Sydney Australia, patron and founder of Namaste Care International and patron of Soul Midwives and Hope for Home a voluntary organization in the United Kingdom.  She is a private geriatric consultant residing in Land O Lakes, Florida in the winter and Prague Czech Republic during the summer months.  She has been involved in long-term care for over 40 years serving as Alzheimer’s specialist for many healthcare companies providing services in skilled nursing homes, assisted living communities and hospice organizations throughout the world. In January of 2013, Provider Magazine recognized her as one of “20 To Watch” for her leadership and commitment to improve the lives of residents in long-term care facilities.

Ms. Simard has written numerous articles and chapters in healthcare books and has authored three books: “The Magic Tape Recorder”, a book for children about Alzheimer’s disease and “The End-of-Life Namaste Care Program for People with Dementia” now in its second edition. She has been involved with grants studying the outcomes of Namaste Care with the School of Nursing, University of Western Sydney, Australia, St. Christopher’s hospice (UK), the University of Worcester (UK) and Lancaster University (UK).  Ms. Simard is a popular speaker for organizations all over the world as she is known for bringing a light touch to serious subjects.

Dr. Volicer is currently the Courtesy Full Professor at the School of Aging Studies, University of South Florida, Tampa, FL, Visiting Professor at the 3rd Medical Faculty, Charles University, Prague, Czech Republic and Adjunct Professor at the University of Western Sydney. He studied medicine at the Charles University in Prague Czechoslovakia and received PhD in pharmacology at the Czechoslovak Academy of Sciences. In 1969, he moved to the USA and started teaching pharmacology and doing research at the Boston University Medical School. In 1979, he moved his laboratory to the E.N.Rogers Memorial Veterans Hospital in Bedford, MA and got involved in research and care for individuals with dementia.

As a medical director, he established one of the first Dementia Special Care Units and introduced the concept of structured palliative care for patients with advanced dementia. Goals of care on this unit were quality of life, dignity and comfort instead of prolongation of life at all costs. Dr. Volicer investigated various aspects of dementia care, including behavioral symptoms, medical complications and eating difficulties. He is recognized as an international expert on advanced dementia care. He published over 250 articles and chapters and edited four books on clinical management of dementia. He is a past chair of the American Medical Directors Association Ethics Committee, section editor for the Journal on Nutrition and Aging and serves on the Editorial Board of the Journal of American Medical Directors Association.

ADI2020 Speaker Alireza Atri

Dr Atri is the Senior Scientist in the Alzheimer’s Prevention Initiative at Banner Sun Health Research Institute. Dr Atri is an internationally renowned cognitive neurologist, clinician-researcher and educator in the fields of Alzheimer’s disease (AD) and Related Dementias (ADRD). His research utilises mathematical/statistical methods, biomarkers, and clinical trial/effectiveness methodologies to focus on early detection, risk reduction, and treatment and care of AD/ADRD. He boasts a BS Mathematics, MS Biomathematics and PhD Biomathematics, UCLA; concurrent with MD, UCSF, amongst many other qualifications.

Dr Atri advises and has led several large international investigational medicines/clinical trials programs for AD. He serves as co-chair of the Alzheimer’s Association U.S. national best clinical practices (AADx-CPG) workgroup on evaluation of cognitive behavioural syndromes, Alzheimer’s disease and ADRD. Dr Atri is also the Vice Chair of Alzheimer’s Disease International’s (ADI), Medical and Scientific Advisory Panel (MSAP).

ADI2020 Speaker Kim Ki Woong

Dr. Kim Ki Woong is a professor of the department of Psychiatry, Seoul National University College of Medicine and the department of Brain and Cognitive Science, Seoul National University College of Natural Sciences, and leading the Center for Dementia and Geriatric Cognitive Disorders in Seoul National University Bundang Hospital.

He graduated from Seoul National University College of Medicine in 1989 and has a Ph.D. in medical science from the Seoul National University Graduate School in 1999. He completed residency in psychiatry and fellowship in geropsychiatry at the Seoul National University Hospital.

His major research interests are neuroimaging, neurophysiology and epidemiology of dementia and dementia policy. He has been leading the Korean Longitudinal Study on Health and Aging (KLOSCHA) since 2005 and the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) since 2009 as the principal investigator. He published more than 300 articles in peer-reviewed journals. Since 2012, he has been working as the first director of the Korean National Institute of Dementia (KNID) and contributed to the development and implementation of Korean national dementia plans.

ADI2020 Speaker Dubhglas and Eileen Taylor

The couple live in Australia and are retired Social Workers, who are actively involved in dementia advocacy both nationally and internationally. Both are on advisory committees for Dementia Australia (DA). Eileen is secretary for Dementia Alliance International (DAI), hosting their online weekly support group for Australian and New Zealand. Both Eileen and Dubhglas are cofounders of the Dementia Awareness Advocacy Team (DAAT).